Heartflow director proposes $2.17M stock sale
The notice also lists a Rule 10b5-1 plan adoption or instruction date of September 12, 2025.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Heartflow, Inc. officer and director John C.M. Farquhar reported a proposed sale of 38,900 common shares, with an aggregate market value of $2,168,286.00 and an approximate sale date of November 10, 2026. The notice lists a Rule 10b5-1 plan adoption or instruction date of September 12, 2025. It also lists an October 12, 2026 sale of 38,900 shares for gross proceeds of $1,928,195.20.
Key Figures
Key Terms
Rule 10b5-1 regulatory
Aggregate Market Value financial
Stock Option Exercise financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Is John C.M. Farquhar's proposed HTFL sale linked to a Rule 10b5-1 plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.